Lv44
570 积分 2022-11-21 加入
Impact of Impaired Renal Function on the Efficacy and Safety of Enfortumab Vedotin Monotherapy in a Multicenter Real-World Cohort of Patients With Metastatic Urothelial Cancer: YUSHIMA Study
6小时前
已完结
A0660 – Validation of prognostic models in patients with metastatic urothelial carcinoma treated with enfortumab vedotin after platinum-based chemotherapy and immune checkpoint inhibitors: YUSHIMA study
8小时前
求助中
Enfortumab vedotin – next game-changer in urothelial cancer
1天前
已完结
Enfortumab vedotin in the treatment of urothelial cancers and beyond
1天前
已完结
Enfortumab vedotin-ejfv for the treatment of advanced urothelial carcinoma
1天前
已完结
Sevabertinib in Advanced HER2-Mutant Non–Small-Cell Lung Cancer
2天前
已完结
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
2天前
已完结
Successful treatment of advanced pulmonary sarcomatoid carcinoma with the PD-1 inhibitor toripalimab: A case report
11天前
已完结
Immunohistochemical study of 36 cases of pulmonary sarcomatoid carcinoma—sensitivity of TTF-1 is superior to napsin
11天前
已完结
Clinical analysis of 95 cases of pulmonary sarcomatoid carcinoma
11天前
已完结
皖公网安备34019202002308
